Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim Academic Article uri icon

Overview

MeSH Major

  • Purpura, Thrombocytopenic, Idiopathic
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin

abstract

  • No clear-cut predictors of remission were apparent; however, a number of patients had ITP for <1 year and received romiplostim for <1 year.

publication date

  • April 20, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1179/1607845415Y.0000000041

PubMed ID

  • 26251926

Additional Document Info

start page

  • 257

end page

  • 62

volume

  • 21

number

  • 4